SIGLEC1 and pneumonia: Regarding pneumonia status, CD169 RMFI was markedly increased in untreated patients with bilateral interstitial pneumonia (BiP) compared to patients without pneumonia or no interstitial pneumonia (p = 0.045), and to patients showing monolateral or minimal interstitial pneumonia (MiP) (p = 0.035).